6FT9
Crystal structure of CLK1 in complex with inhibitor 16
6FT9 の概要
エントリーDOI | 10.2210/pdb6ft9/pdb |
分子名称 | Dual specificity protein kinase CLK1, 2-bromanyl-3-phenyl-1~{H}-pyrrolo[3,4-g]indol-8-one, BROMIDE ION, ... (7 entities in total) |
機能のキーワード | kinase, inhibitor, splicing kinase, clk, structural genomics, structural genomics consortium, sgc, transferase |
由来する生物種 | Homo sapiens (Human) |
細胞内の位置 | Nucleus: P49759 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 120774.08 |
構造登録者 | Chaikuad, A.,Walter, A.,von Delft, F.,Bountra, C.,Arrowsmith, C.H.,Edwards, A.M.,Kunick, C.,Knapp, S.,Structural Genomics Consortium (SGC) (登録日: 2018-02-20, 公開日: 2018-05-16, 最終更新日: 2024-01-17) |
主引用文献 | Walter, A.,Chaikuad, A.,Helmer, R.,Loaec, N.,Preu, L.,Ott, I.,Knapp, S.,Meijer, L.,Kunick, C. Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype. PLoS ONE, 13:e0196761-e0196761, 2018 Cited by PubMed Abstract: Cdc2-like kinases (CLKs) represent a family of serine-threonine kinases involved in the regulation of splicing by phosphorylation of SR-proteins and other splicing factors. Although compounds acting against CLKs have been described, only a few show selectivity against dual-specificity tyrosine phosphorylation regulated-kinases (DYRKs). We here report a novel CLK inhibitor family based on a 6,7-dihydropyrrolo[3,4-g]indol-8(1H)-one core scaffold. Within the series, 3-(3-chlorophenyl)-6,7-dihydropyrrolo[3,4-g]indol-8(1H)-one (KuWal151) was identified as inhibitor of CLK1, CLK2 and CLK4 with a high selectivity margin towards DYRK kinases. The compound displayed a potent antiproliferative activity in an array of cultured cancer cell lines. The X-ray structure analyses of three members of the new compound class co-crystallized with CLK proteins corroborated a molecular binding mode predicted by docking studies. PubMed: 29723265DOI: 10.1371/journal.pone.0196761 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.87 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード